#1 Clinical Trials Search in Europe

Gentamicin Sulfate

Gentamicin sulfate, a well-known antibiotic, is being investigated in clinical trials for its potential to treat rare genetic disorders and prevent urinary tract infections. Researchers are exploring how gentamicin may help patients with conditions like epidermolysis bullosa and junctional epidermolysis bullosa by enabling the production of essential proteins. Additionally, studies are examining gentamicin’s effectiveness in preventing urinary tract infections in patients with spinal cord injuries or those undergoing certain surgeries. This article summarizes key findings from recent clinical trials using gentamicin sulfate for these innovative applications.

Table of Contents

What is Gentamicin Sulfate?

Gentamicin Sulfate, also known as Gentamicin or Garamycin, is an antibiotic medication that has been used for over four decades to treat various bacterial infections[1]. It belongs to a class of drugs called aminoglycosides, which work by stopping the growth of bacteria[1].

What makes Gentamicin Sulfate unique is its ability to not only fight infections but also potentially help treat certain genetic conditions. Recent research has shown that Gentamicin can sometimes help cells “read through” or bypass certain genetic mutations, potentially restoring the production of important proteins in some rare diseases[1].

Medical Uses of Gentamicin Sulfate

Gentamicin Sulfate is used to treat a variety of conditions, including:

  • Urinary Tract Infections (UTIs): Especially in people with spinal cord injuries or other neurological conditions affecting bladder function[2][3].
  • Skin Infections: Particularly in patients with rare genetic skin conditions like Epidermolysis Bullosa (EB) and Junctional Epidermolysis Bullosa (JEB)[4][5].
  • Genetic Disorders: Research is exploring its use in treating certain genetic conditions caused by specific types of mutations, such as Hereditary Hypotrichosis Simplex (a rare hair loss disorder)[6].
  • Prevention of Infections: It’s being studied for preventing infections in certain situations, such as after surgeries for pelvic organ prolapse or stress urinary incontinence[7].

How Gentamicin Sulfate is Administered

Gentamicin Sulfate can be given in several ways, depending on the condition being treated:

  • Intravenous (IV) Infusion: Given directly into a vein, usually for more severe infections or certain genetic conditions[8].
  • Topical Application: Applied directly to the skin as a cream or ointment for skin conditions or wounds[4].
  • Bladder Instillation: A solution of Gentamicin is put directly into the bladder through a catheter to treat or prevent urinary tract infections[2].
  • Intravesical Instillation: Similar to bladder instillation, this method involves putting the medication directly into the bladder, often used after certain surgeries[7].

Current Research and Clinical Trials

Gentamicin Sulfate is currently being studied for several innovative uses:

  • Treating Rare Skin Disorders: Research is exploring whether Gentamicin can help restore important skin proteins in conditions like Epidermolysis Bullosa and Junctional Epidermolysis Bullosa[4][5].
  • Hair Loss Treatment: A study is investigating if topical Gentamicin can help with a rare form of hereditary hair loss[6].
  • Preventing Post-Surgical Infections: Researchers are studying whether a single dose of Gentamicin in the bladder after certain pelvic surgeries can prevent urinary tract infections[7].
  • Managing Chronic UTIs: Studies are looking at whether regular Gentamicin bladder instillations can reduce the frequency of UTIs in people with spinal cord injuries[2][3].

Potential Side Effects and Safety Considerations

While Gentamicin Sulfate can be an effective treatment, it’s important to be aware of potential side effects:

  • Ototoxicity: This means damage to the ears, which can affect hearing or balance. Doctors carefully monitor for this, especially with long-term or high-dose use[8].
  • Nephrotoxicity: This refers to damage to the kidneys. Kidney function is closely monitored during treatment[8].
  • Allergic Reactions: As with any medication, some people may have allergic reactions to Gentamicin.
  • Development of Antibiotic-Resistant Bacteria: Long-term use of antibiotics can sometimes lead to the development of resistant bacteria, which is why Gentamicin is used carefully and only when necessary[9].

It’s crucial to note that Gentamicin Sulfate should only be used under the close supervision of a healthcare professional. They will carefully weigh the potential benefits against the risks for each individual patient.

Condition Study Design Intervention Key Outcomes
Recessive Dystrophic Epidermolysis Bullosa (RDEB) Open-label, single-arm study Topical, intradermal, and intravenous gentamicin Increased type VII collagen and anchoring fibrils, improved wound closure
Junctional Epidermolysis Bullosa (JEB) Open-label, single-arm study Topical and intravenous gentamicin Increased laminin 332 expression, improved wound closure
Urinary Tract Infections in Spinal Cord Injury Patients Randomized, controlled trial Gentamicin bladder instillations Reduced UTI rates, improved bladder function
Post-operative Urinary Tract Infections Randomized, single-masked trial Single post-operative intravesical gentamicin instillation Reduced UTI rates within 6 weeks after surgery
Hereditary Hypotrichosis Simplex Open-label, single-arm study Topical gentamicin Increased hair density, presence of vellus hairs

FAQ

  • What is gentamicin sulfate being studied for in clinical trials? Gentamicin sulfate is being studied for treating rare genetic disorders like epidermolysis bullosa and junctional epidermolysis bullosa, as well as preventing urinary tract infections in patients with spinal cord injuries or those undergoing certain surgeries.
  • How might gentamicin help patients with epidermolysis bullosa? Gentamicin may help patients with epidermolysis bullosa by enabling the production of essential proteins like type VII collagen or laminin 332, which are crucial for proper skin function and are often missing or defective in these patients.
  • What are some potential benefits of using gentamicin for urinary tract infections? Using gentamicin for urinary tract infections may help reduce infection rates, decrease the need for oral antibiotics, and improve quality of life for patients prone to recurrent UTIs, such as those with spinal cord injuries.
  • How is gentamicin being administered in these clinical trials? Gentamicin is being administered in various ways depending on the study, including topical application, intravenous infusion, bladder instillation, and intradermal injection using a microneedle roller device.
  • Are there any potential side effects of gentamicin treatment being monitored in these trials? Yes, potential side effects being monitored include ototoxicity (hearing loss), nephrotoxicity (kidney damage), and the development of autoantibodies against newly produced proteins. Regular tests are conducted to ensure patient safety.

Ongoing Clinical Trials on Gentamicin Sulfate

  • Study comparing dalbavancin to standard antibiotic treatment for patients with periprosthetic joint infection

    Recruiting

    3 1 1 1
    Investigated drugs:
    Denmark

  • Comparing pivmecillinam and gentamicin with standard treatments for hospitalized adults with complicated urinary tract infections

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study of pivmecillinam compared to standard antibiotics for treating Escherichia coli urinary tract infection with fever

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Norway Sweden

  • Comparison of Gentamicin with Narrow-Spectrum Antibiotics versus Broad-Spectrum Antibiotics in Adult Patients with Early Sepsis

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Norway

  • Study on How Gut Bacteria Affect Energy Use in Cells for Healthy Adults and Patients with Inflammatory Bowel Disease Using Amphotericin B, Vancomycin, and Gentamicin Sulfate

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Betamethasone Sodium Phosphate and Drug Combination for Pregnant Women with Preterm Premature Rupture of Membranes

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia

  • Study Comparing Dalbavancin to Standard Antibiotics for Patients with Staphylococcus aureus Bloodstream Infections

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on the Effects of Injectable Gentamicin for Patients with Moderate to Severe Congenital Ichthyosis

    Recruiting

    2 1 1 1
    Investigated drugs:
    France

  • Study of Aztreonam-Avibactam and Metronidazole for Children with Serious Gram-Negative Bacterial Infections

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Greece Hungary Spain

  • Study of antibiotic treatment effectiveness in critically ill patients receiving drug combination therapy

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    France

Glossary

  • Epidermolysis bullosa (EB): A group of rare genetic disorders that cause the skin to be fragile and blister easily. There are different types of EB, including recessive dystrophic EB (RDEB) and junctional EB (JEB).
  • Junctional epidermolysis bullosa (JEB): A type of EB caused by mutations in genes that produce laminin 332, a protein essential for skin integrity.
  • Laminin 332: A protein that helps attach the epidermis (outer layer of skin) to the dermis (inner layer of skin). It is often deficient in patients with junctional epidermolysis bullosa.
  • Type VII collagen: A protein that forms anchoring fibrils, which help attach the epidermis to the dermis. It is often deficient in patients with recessive dystrophic epidermolysis bullosa.
  • Nonsense mutation: A genetic mutation that results in a premature stop codon, leading to the production of a shortened, non-functional protein.
  • Read-through: The process by which certain drugs, like gentamicin, can enable the cellular machinery to bypass premature stop codons and produce full-length, functional proteins.
  • Dermal-epidermal junction (DEJ): The area where the epidermis (outer layer of skin) and dermis (inner layer of skin) meet. This is often where blistering occurs in patients with epidermolysis bullosa.
  • Anchoring fibrils: Structures made of type VII collagen that help attach the epidermis to the dermis, providing skin stability.
  • Neurogenic bladder: A condition where nerve damage affects bladder function, often seen in patients with spinal cord injuries.
  • Bladder instillation: A procedure where a medication is directly inserted into the bladder through a catheter.
  • Ototoxicity: Damage to the ear (particularly to the cochlea or auditory nerve) caused by certain medications, potentially leading to hearing loss.
  • Nephrotoxicity: Damage to the kidneys caused by certain medications or substances.
  • Immunofluorescence: A laboratory technique used to detect specific proteins in tissue samples using fluorescent antibodies.
  • Electron microscopy: A high-resolution imaging technique used to visualize extremely small structures, such as anchoring fibrils in skin samples.

References

  1. https://clinicaltrials.gov/study/NCT03526159
  2. https://clinicaltrials.gov/study/NCT03503513
  3. https://clinicaltrials.gov/study/NCT03931408
  4. https://clinicaltrials.gov/study/NCT04644627
  5. https://clinicaltrials.gov/study/NCT03012191
  6. https://clinicaltrials.gov/study/NCT03492866
  7. https://clinicaltrials.gov/study/NCT04246996
  8. https://clinicaltrials.gov/study/NCT04140786
  9. https://clinicaltrials.gov/study/NCT05143164